APO Research, Inc.

APO RESEARCH · REPORT

IV Administration Primary Set

Selected research

Market Structure

Global IV Administration Primary Set Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global IV Administration Primary Set market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IV Administration Primary Set include BD, SB Kawasumi, Amsino, Bayer, Baxter International, Zyno Medical, Smiths Medical, MPS Medical and Medtec Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global IV Administration Primary Set market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IV Administration Primary Set and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IV Administration Primary Set sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the IV Administration Primary Set market size, projected growth trends, production technologies, key applications, and end-use industries.

IV Administration Primary Set Segment by Company

BD

SB Kawasumi

Amsino

Bayer

Baxter International

Zyno Medical

Smiths Medical

MPS Medical

Medtec Medical

MedSource Labs

ICU Medical

Eitan Group

CODAN US Corporation

B. Braun

Advanced Medical Systems

3M

IV Administration Primary Set Segment by Type

1 - 200 Micron

More Than 200 Micron

Less Than 1 Micron

IV Administration Primary Set Segment by Application

Hospitals

Clinics

Other

IV Administration Primary Set Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IV Administration Primary Set market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IV Administration Primary Set and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IV Administration Primary Set.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the IV Administration Primary Set market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IV Administration Primary Set manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of IV Administration Primary Set in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of IV Administration Primary Set in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. IV Administration Primary Set Industry Trends Table 2. IV Administration Primary Set Industry Drivers Table 3. IV Administration Primary Set Industry Opportunities and Challenges Table 4. IV Administration Primary Set Industry Restraints Table 5. Global IV Administration Primary Set Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global IV Administration Primary Set Revenue Market Share by Manufacturers (2021-2026) Table 7. Global IV Administration Primary Set Sales by Manufacturers (k units) & (2021-2026) Table 8. Global IV Administration Primary Set Sales Market Share by Manufacturers Table 9. Global IV Administration Primary Set Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global IV Administration Primary Set Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global IV Administration Primary Set Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global IV Administration Primary Set Manufacturers, Product Type & Application Table 13. Global IV Administration Primary Set Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global IV Administration Primary Set by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1 - 200 Micron Table 17. Major Manufacturers of More Than 200 Micron Table 18. Major Manufacturers of Less Than 1 Micron Table 19. Global IV Administration Primary Set Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global IV Administration Primary Set Sales by Type (2021-2026) & (k units) Table 21. Global IV Administration Primary Set Sales by Type (2027-2032) & (k units) Table 22. Global IV Administration Primary Set Sales Market Share by Type (2021-2026) Table 23. Global IV Administration Primary Set Sales Market Share by Type (2027-2032) Table 24. Global IV Administration Primary Set Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global IV Administration Primary Set Revenue by Type (2021-2026) & (k units) Table 26. Global IV Administration Primary Set Revenue by Type (2027-2032) & (k units) Table 27. Global IV Administration Primary Set Revenue Market Share by Type (2021-2026) Table 28. Global IV Administration Primary Set Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Other Table 32. Global IV Administration Primary Set Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global IV Administration Primary Set Sales by Application (2021-2026) & (k units) Table 34. Global IV Administration Primary Set Sales by Application (2027-2032) & (k units) Table 35. Global IV Administration Primary Set Sales Market Share by Application (2021-2026) Table 36. Global IV Administration Primary Set Sales Market Share by Application (2027-2032) Table 37. Global IV Administration Primary Set Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global IV Administration Primary Set Revenue by Application (2021-2026) & (k units) Table 39. Global IV Administration Primary Set Revenue by Application (2027-2032) & (k units) Table 40. Global IV Administration Primary Set Revenue Market Share by Application (2021-2026) Table 41. Global IV Administration Primary Set Revenue Market Share by Application (2027-2032) Table 42. Global IV Administration Primary Set Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global IV Administration Primary Set Sales by Region (2021-2026) & (k units) Table 44. Global IV Administration Primary Set Sales Market Share by Region (2021-2026) Table 45. Global IV Administration Primary Set Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global IV Administration Primary Set Sales Forecasted Market Share by Region (2027-2032) Table 47. North America IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America IV Administration Primary Set Sales by Country (2021-2026) & (k units) Table 49. North America IV Administration Primary Set Sales by Country (2027-2032) & (k units) Table 50. Europe IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe IV Administration Primary Set Sales by Country (2021-2026) & (k units) Table 52. Europe IV Administration Primary Set Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific IV Administration Primary Set Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific IV Administration Primary Set Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa IV Administration Primary Set Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa IV Administration Primary Set Sales by Country (2027-2032) & (k units) Table 59. Global IV Administration Primary Set Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global IV Administration Primary Set Revenue by Region (2021-2026) & (US$ Million) Table 61. Global IV Administration Primary Set Revenue by Region (2027-2032) & (US$ Million) Table 62. Global IV Administration Primary Set Revenue Market Share by Region (2021-2026) Table 63. Global IV Administration Primary Set Revenue Market Share by Region (2027-2032) Table 64. BD Company Information Table 65. BD Business Overview Table 66. BD IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. BD IV Administration Primary Set Product Portfolio Table 68. BD Recent Development Table 69. SB Kawasumi Company Information Table 70. SB Kawasumi Business Overview Table 71. SB Kawasumi IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. SB Kawasumi IV Administration Primary Set Product Portfolio Table 73. SB Kawasumi Recent Development Table 74. Amsino Company Information Table 75. Amsino Business Overview Table 76. Amsino IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Amsino IV Administration Primary Set Product Portfolio Table 78. Amsino Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bayer IV Administration Primary Set Product Portfolio Table 83. Bayer Recent Development Table 84. Baxter International Company Information Table 85. Baxter International Business Overview Table 86. Baxter International IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Baxter International IV Administration Primary Set Product Portfolio Table 88. Baxter International Recent Development Table 89. Zyno Medical Company Information Table 90. Zyno Medical Business Overview Table 91. Zyno Medical IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Zyno Medical IV Administration Primary Set Product Portfolio Table 93. Zyno Medical Recent Development Table 94. Smiths Medical Company Information Table 95. Smiths Medical Business Overview Table 96. Smiths Medical IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Smiths Medical IV Administration Primary Set Product Portfolio Table 98. Smiths Medical Recent Development Table 99. MPS Medical Company Information Table 100. MPS Medical Business Overview Table 101. MPS Medical IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. MPS Medical IV Administration Primary Set Product Portfolio Table 103. MPS Medical Recent Development Table 104. Medtec Medical Company Information Table 105. Medtec Medical Business Overview Table 106. Medtec Medical IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Medtec Medical IV Administration Primary Set Product Portfolio Table 108. Medtec Medical Recent Development Table 109. MedSource Labs Company Information Table 110. MedSource Labs Business Overview Table 111. MedSource Labs IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. MedSource Labs IV Administration Primary Set Product Portfolio Table 113. MedSource Labs Recent Development Table 114. ICU Medical Company Information Table 115. ICU Medical Business Overview Table 116. ICU Medical IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. ICU Medical IV Administration Primary Set Product Portfolio Table 118. ICU Medical Recent Development Table 119. Eitan Group Company Information Table 120. Eitan Group Business Overview Table 121. Eitan Group IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Eitan Group IV Administration Primary Set Product Portfolio Table 123. Eitan Group Recent Development Table 124. CODAN US Corporation Company Information Table 125. CODAN US Corporation Business Overview Table 126. CODAN US Corporation IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. CODAN US Corporation IV Administration Primary Set Product Portfolio Table 128. CODAN US Corporation Recent Development Table 129. B. Braun Company Information Table 130. B. Braun Business Overview Table 131. B. Braun IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. B. Braun IV Administration Primary Set Product Portfolio Table 133. B. Braun Recent Development Table 134. Advanced Medical Systems Company Information Table 135. Advanced Medical Systems Business Overview Table 136. Advanced Medical Systems IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Advanced Medical Systems IV Administration Primary Set Product Portfolio Table 138. Advanced Medical Systems Recent Development Table 139. 3M Company Information Table 140. 3M Business Overview Table 141. 3M IV Administration Primary Set Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. 3M IV Administration Primary Set Product Portfolio Table 143. 3M Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. IV Administration Primary Set Distributors List Table 147. IV Administration Primary Set Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. IV Administration Primary Set Product Image Figure 2. Global IV Administration Primary Set Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IV Administration Primary Set Market Size (2021-2032) & (US$ Million) Figure 4. Global IV Administration Primary Set Sales (2021-2032) & (k units) Figure 5. Global IV Administration Primary Set Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 IV Administration Primary Set Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1 - 200 Micron Image Figure 9. More Than 200 Micron Image Figure 10. Less Than 1 Micron Image Figure 11. Global IV Administration Primary Set Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global IV Administration Primary Set Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global IV Administration Primary Set Sales Market Share by Type (2021-2032) Figure 14. Global IV Administration Primary Set Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global IV Administration Primary Set Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global IV Administration Primary Set Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Other Image Figure 20. Global IV Administration Primary Set Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global IV Administration Primary Set Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global IV Administration Primary Set Sales Market Share by Application (2021-2032) Figure 23. Global IV Administration Primary Set Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global IV Administration Primary Set Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global IV Administration Primary Set Revenue Market Share by Application (2021-2032) Figure 26. North America IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America IV Administration Primary Set Sales Market Share by Country (2021-2032) Figure 28. U.S. IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe IV Administration Primary Set Sales Market Share by Country (2021-2032) Figure 33. Germany IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 34. France IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific IV Administration Primary Set Sales Market Share by Country (2021-2032) Figure 40. China IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 44. India IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa IV Administration Primary Set Sales Market Share by Country (2021-2032) Figure 48. Brazil IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile IV Administration Primary Set Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global IV Administration Primary Set Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global IV Administration Primary Set Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America IV Administration Primary Set Revenue (2021-2032) & (US$ Million) Figure 59. North America IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe IV Administration Primary Set Revenue (2021-2032) & (US$ Million) Figure 61. Europe IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific IV Administration Primary Set Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa IV Administration Primary Set Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. IV Administration Primary Set Value Chain Figure 67. Manufacturing Cost Structure Figure 68. IV Administration Primary Set Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1 - 200 Micron
  • More Than 200 Micron
  • Less Than 1 Micron
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • BD
  • SB Kawasumi
  • Amsino
  • Bayer
  • Baxter International
  • Zyno Medical
  • Smiths Medical
  • MPS Medical
  • Medtec Medical
  • MedSource Labs
  • ICU Medical
  • Eitan Group
  • CODAN US Corporation
  • B. Braun
  • Advanced Medical Systems
  • 3M

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global IV Administration Primary Set Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global IV Administration Primary Set Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global IV Administration Primary Set Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global IV Administration Primary Set Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global IV Administration Primary Set Market Dynamics
  1. 2.1 IV Administration Primary Set Industry Trends
  2. 2.2 IV Administration Primary Set Industry Drivers
  3. 2.3 IV Administration Primary Set Industry Opportunities and Challenges
  4. 2.4 IV Administration Primary Set Industry Restraints
3 IV Administration Primary Set Market by Manufacturers
  1. 3.1 Global IV Administration Primary Set Revenue by Manufacturers (2021-2026)
  2. 3.2 Global IV Administration Primary Set Sales by Manufacturers (2021-2026)
  3. 3.3 Global IV Administration Primary Set Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global IV Administration Primary Set Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IV Administration Primary Set Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global IV Administration Primary Set Manufacturers, Product Type & Application
  7. 3.7 Global IV Administration Primary Set Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IV Administration Primary Set Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IV Administration Primary Set Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IV Administration Primary Set Tier 1, Tier 2, and Tier 3
4 IV Administration Primary Set Market by Type
  1. 4.1 IV Administration Primary Set Type Introduction
  2. 4.1.1 1 - 200 Micron
  3. 4.1.2 More Than 200 Micron
  4. 4.1.3 Less Than 1 Micron
  5. 4.2 Global IV Administration Primary Set Sales by Type
  6. 4.2.1 Global IV Administration Primary Set Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global IV Administration Primary Set Sales by Type (2021-2032)
  8. 4.2.3 Global IV Administration Primary Set Sales Market Share by Type (2021-2032)
  9. 4.3 Global IV Administration Primary Set Revenue by Type
  10. 4.3.1 Global IV Administration Primary Set Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global IV Administration Primary Set Revenue by Type (2021-2032)
  12. 4.3.3 Global IV Administration Primary Set Revenue Market Share by Type (2021-2032)
5 IV Administration Primary Set Market by Application
  1. 5.1 IV Administration Primary Set Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global IV Administration Primary Set Sales by Application
  6. 5.2.1 Global IV Administration Primary Set Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global IV Administration Primary Set Sales by Application (2021-2032)
  8. 5.2.3 Global IV Administration Primary Set Sales Market Share by Application (2021-2032)
  9. 5.3 Global IV Administration Primary Set Revenue by Application
  10. 5.3.1 Global IV Administration Primary Set Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global IV Administration Primary Set Revenue by Application (2021-2032)
  12. 5.3.3 Global IV Administration Primary Set Revenue Market Share by Application (2021-2032)
6 Global IV Administration Primary Set Sales by Region
  1. 6.1 Global IV Administration Primary Set Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IV Administration Primary Set Sales by Region (2021-2032)
  3. 6.2.1 Global IV Administration Primary Set Sales by Region (2021-2026)
  4. 6.2.2 Global IV Administration Primary Set Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America IV Administration Primary Set Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe IV Administration Primary Set Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific IV Administration Primary Set Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa IV Administration Primary Set Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global IV Administration Primary Set Revenue by Region
  1. 7.1 Global IV Administration Primary Set Revenue by Region
  2. 7.1.1 Global IV Administration Primary Set Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global IV Administration Primary Set Revenue by Region (2021-2026)
  4. 7.1.3 Global IV Administration Primary Set Revenue by Region (2027-2032)
  5. 7.1.4 Global IV Administration Primary Set Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America IV Administration Primary Set Revenue (2021-2032)
  8. 7.2.2 North America IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe IV Administration Primary Set Revenue (2021-2032)
  11. 7.3.2 Europe IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific IV Administration Primary Set Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa IV Administration Primary Set Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BD IV Administration Primary Set Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 SB Kawasumi
  8. 8.2.1 SB Kawasumi Company Information
  9. 8.2.2 SB Kawasumi Business Overview
  10. 8.2.3 SB Kawasumi IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SB Kawasumi IV Administration Primary Set Product Portfolio
  12. 8.2.5 SB Kawasumi Recent Developments
  13. 8.3 Amsino
  14. 8.3.1 Amsino Company Information
  15. 8.3.2 Amsino Business Overview
  16. 8.3.3 Amsino IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amsino IV Administration Primary Set Product Portfolio
  18. 8.3.5 Amsino Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer IV Administration Primary Set Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Baxter International
  26. 8.5.1 Baxter International Company Information
  27. 8.5.2 Baxter International Business Overview
  28. 8.5.3 Baxter International IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Baxter International IV Administration Primary Set Product Portfolio
  30. 8.5.5 Baxter International Recent Developments
  31. 8.6 Zyno Medical
  32. 8.6.1 Zyno Medical Company Information
  33. 8.6.2 Zyno Medical Business Overview
  34. 8.6.3 Zyno Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zyno Medical IV Administration Primary Set Product Portfolio
  36. 8.6.5 Zyno Medical Recent Developments
  37. 8.7 Smiths Medical
  38. 8.7.1 Smiths Medical Company Information
  39. 8.7.2 Smiths Medical Business Overview
  40. 8.7.3 Smiths Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Smiths Medical IV Administration Primary Set Product Portfolio
  42. 8.7.5 Smiths Medical Recent Developments
  43. 8.8 MPS Medical
  44. 8.8.1 MPS Medical Company Information
  45. 8.8.2 MPS Medical Business Overview
  46. 8.8.3 MPS Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MPS Medical IV Administration Primary Set Product Portfolio
  48. 8.8.5 MPS Medical Recent Developments
  49. 8.9 Medtec Medical
  50. 8.9.1 Medtec Medical Company Information
  51. 8.9.2 Medtec Medical Business Overview
  52. 8.9.3 Medtec Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medtec Medical IV Administration Primary Set Product Portfolio
  54. 8.9.5 Medtec Medical Recent Developments
  55. 8.10 MedSource Labs
  56. 8.10.1 MedSource Labs Company Information
  57. 8.10.2 MedSource Labs Business Overview
  58. 8.10.3 MedSource Labs IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MedSource Labs IV Administration Primary Set Product Portfolio
  60. 8.10.5 MedSource Labs Recent Developments
  61. 8.11 ICU Medical
  62. 8.11.1 ICU Medical Company Information
  63. 8.11.2 ICU Medical Business Overview
  64. 8.11.3 ICU Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ICU Medical IV Administration Primary Set Product Portfolio
  66. 8.11.5 ICU Medical Recent Developments
  67. 8.12 Eitan Group
  68. 8.12.1 Eitan Group Company Information
  69. 8.12.2 Eitan Group Business Overview
  70. 8.12.3 Eitan Group IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eitan Group IV Administration Primary Set Product Portfolio
  72. 8.12.5 Eitan Group Recent Developments
  73. 8.13 CODAN US Corporation
  74. 8.13.1 CODAN US Corporation Company Information
  75. 8.13.2 CODAN US Corporation Business Overview
  76. 8.13.3 CODAN US Corporation IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CODAN US Corporation IV Administration Primary Set Product Portfolio
  78. 8.13.5 CODAN US Corporation Recent Developments
  79. 8.14 B. Braun
  80. 8.14.1 B. Braun Company Information
  81. 8.14.2 B. Braun Business Overview
  82. 8.14.3 B. Braun IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 B. Braun IV Administration Primary Set Product Portfolio
  84. 8.14.5 B. Braun Recent Developments
  85. 8.15 Advanced Medical Systems
  86. 8.15.1 Advanced Medical Systems Company Information
  87. 8.15.2 Advanced Medical Systems Business Overview
  88. 8.15.3 Advanced Medical Systems IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Advanced Medical Systems IV Administration Primary Set Product Portfolio
  90. 8.15.5 Advanced Medical Systems Recent Developments
  91. 8.16 3M
  92. 8.16.1 3M Company Information
  93. 8.16.2 3M Business Overview
  94. 8.16.3 3M IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 3M IV Administration Primary Set Product Portfolio
  96. 8.16.5 3M Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 IV Administration Primary Set Value Chain Analysis
  2. 9.1.1 IV Administration Primary Set Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 IV Administration Primary Set Production Mode & Process
  6. 9.2 IV Administration Primary Set Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 IV Administration Primary Set Distributors
  9. 9.2.3 IV Administration Primary Set Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.